Question normal

The case portrays the insurance company as the instigator of the patient's opioid taper, forcing it insidiously via prior auths and requiring frequent refills, when the PCP otherwise seemed to feel that continuing the regimen was appropriate. I wonder if clinicians have examples of success pushing back against insurance company interference in their care plan, either individually or through organized efforts, that we could all learn from. I also wonder if we might take this case as an example of how a single-payer system might have averted a harmful outcome, or whether something similar may have happened under a Medicare plan.